Premier Research: holistic approach benefits development
WEBOct 6, 2020 · Holistic design starts off with designing a target product profile that considers the end goal early in the development planning. Also, part of a successful holistic approach, Sharif suggested, is asking thoughtful, appropriate questions at the outset, making sure to consider outcome-focused impactful issues at every stage of development.
After private equity buyout, Millstone grows through takeover of ...
WEBDec 1, 2022 · MycoScience’s capabilities caught the attention of Millstone, a US provider of post-manufacturing and aftermarket services. Millstone CEO Karl Neuberger outlined the rationale for the takeover. The takeover comes 11 months after the private equity firm Arlington Capital Partners bought Millstone. At the time, Neuberger said the deal would ...
The rise of the integrated research organization: A conversation …
WEBSep 11, 2019 · Behind the term is NC-based Javara, which made its official debut in June 2018 . The company’s CEO Jennifer Byrne told us the name ‘integrated research organization,’ or IRO, emerged as the descriptor for the new clinical research model following discussions with Wake Forest Baptist Health.
AxoSim's acquisition of microBrain to transform neurological R&D
WEBOct 23, 2023 · AxoSim Inc., is in the field of development and application of live biometric human drug discovery platforms for neurological diseases announced yesterday (October 24) the acquisition of microBrain-associated assets of Vyant Bio’s Stemonix subsidiary. The acquisition includes the microBrain drug discovery platform, a 14,000 square foot R&D ...
Sanofi unveils EUROAPI as name of new API company
WEBJan 14, 2021 · Sanofi has unveiled EUROAPI as the name of its new European active pharmaceutical ingredients (API) company. Additionally, the firm has appointed Karl Rotthier as its future CEO. According to Sanofi, the new company stands to be the largest API organization in the European Union, with projected sales …
ICON to acquire PRA Health Sciences in $12b deal
WEBFeb 25, 2021 · ICON, a Dublin-based contract research organization (CRO) has entered into an agreement to acquire PRA Health Sciences, another CRO currently sited in Raleigh, North Carolina. The arrangement comprises a cash and stock transaction valued at approximately $12bn USD. According to company leaders, the transaction stands to benefit pharmaceutical ...
Making the most of trial data can benefit patients: Parexel
WEBOct 5, 2021 · Collecting data in clinical research and drug development is important, but what matters is collecting the right data, using it well, and making connections that ultimately provide the greatest benefit to patients. Michelle Hoiseth, chief data officer with Parexel, discussed data linking with Outsourcing-Pharma and how it can elevate results.
IQVIA expands reach of its decentralized trial solutions
WEBMar 24, 2021 · PS: More than 60 trials spanning over 40 countries utilize IQVIA’s innovative decentralized clinical trial solutions as part of their respective registration trials. Many of these trials launched in 2020 as DCT and patient-centric solutions are providing business continuity measures to sponsors during the global pandemic.
Covance to close Arizona tox site as weak demand continues
WEBMay 3, 2012 · Covance is to close its toxicology facility in Arizona after early development demand dipped at the start of 2012. Talk of possible cuts emerged from Covance in January and after a slow start to the calendar year the axe has fallen on the preclinical site in Chandler, Arizona. Covance opened the facility in 2009 but changes to the contract with ...
Bill aims to encourage US pharmaceutical manufacturing
WEBMay 3, 2022 · Proposed bill aims to encourage US pharmaceutical manufacturing. Introduced by two Republican Congressmen, the American Made Medicine Act is intended to boost domestic drug manufacturing and create jobs in the sector. Congressmen Brad Wenstrup (R-Ohio) and Drew Ferguson (R-Georgia) have introduced the …